Jefferies maintains Novo Nordisk B at Underperform, PT $850.00

  • Investing.com
Jefferies maintains Novo Nordisk B at Underperform, PT $850.00

A Jefferies analyst maintained Novo Nordisk B (CSE: NOVOb) at Underperform and a price target of $850.00 from a prior price target of DKK730.00.

Prior to this rating, Novo Nordisk B had 15 buy ratings, 3 hold ratings, and 4 sell ratings.

For consensus analyst estimates and price targets on Novo Nordisk B, click here. For more news on Novo Nordisk B, click here.

Novo Nordisk B's stock price closed at $1.0. They are down -99.9% in the last month and up 46.3% in the last 12 months.

According to Investing Pro, Novo Nordisk B's fair value is $982.6, an upside of -15.8%. Novo Nordisk B's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Novo Nordisk B's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100